[et_pb_section fb_built=”1″ fullwidth=”on” admin_label=”Hero Section” _builder_version=”3.29.3″ global_module=”772″ saved_tabs=”all”][et_pb_fullwidth_header title=”News ” subhead=”read more” background_overlay_color=”rgba(0,0,0,0.61)” content_max_width=”550px” _builder_version=”3.29.3″ title_font=”Poppins|700||on|||||” title_text_color=”#edbb5f” title_font_size=”14px” title_letter_spacing=”2px” title_line_height=”1.4em” content_font=”Poppins||||||||” content_font_size=”16px” content_letter_spacing=”1px” content_line_height=”2em” subhead_font=”Playfair Display|700||on|||||” subhead_font_size=”48px” subhead_letter_spacing=”3px” subhead_line_height=”1.4em” background_color=”rgba(255, 255, 255, 0)” background_image=”http:\/\/app-pharma.care\/wp-content\/uploads\/2019\/09\/cellphone-coffee-desk-860379.jpg” parallax=”on” parallax_method=”on” custom_button_one=”on” button_one_border_width=”1px” button_one_border_color=”rgba(255,255,255,0.3)” button_one_border_radius=”0px” button_one_letter_spacing=”1px” button_one_font=”Saira Extra Condensed|600||on|||||” button_one_icon=”%%3%%” button_one_icon_color=”#edbb5f” custom_button_two=”on” button_two_border_width=”1px” button_two_border_color=”rgba(255,255,255,0.3)” button_two_border_radius=”0px” button_two_letter_spacing=”1px” button_two_font=”Saira Extra Condensed|600||on|||||” button_two_icon=”%%3%%” button_two_icon_color=”#edbb5f” module_alignment=”right” min_height=”317px” custom_margin=”|||” custom_padding=”4%||5%|||” button_one_text_color_hover=”#edbb5f” button_two_text_color_hover=”#edbb5f” button_one_bg_color_hover=”rgba(0,0,0,0)” button_two_bg_color_hover=”rgba(0,0,0,0)” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_one_text_color__hover_enabled=”on” button_one_text_color__hover=”#edbb5f” button_two_text_color__hover_enabled=”on” button_two_text_color__hover=”#edbb5f” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_one_bg_color__hover_enabled=”on” button_one_bg_color__hover=”rgba(0,0,0,0)” button_two_bg_color__hover_enabled=”on” button_two_bg_color__hover=”rgba(0,0,0,0)”]<\/p>\n
<\/p>\n
<\/p>\n
[\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”news” _builder_version=”3.27.4″ custom_margin=”|||” custom_padding=”100px|0px|19px|0px||”][et_pb_row use_custom_gutter=”on” gutter_width=”4″ _builder_version=”3.25″ animation_style=”fade”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_post_title _builder_version=”3.27.4″ title_font=”Playfair Display|700|||||||” title_font_size=”32px” meta_font=”Poppins||||||||”][\/et_pb_post_title][et_pb_divider color=”#edbb5f” divider_weight=”2px” _builder_version=”3.2″ max_width=”60px” module_alignment=”left” height=”2px” global_module=”350″ saved_tabs=”all”][\/et_pb_divider][et_pb_text _builder_version=”3.27.4″ text_font=”Poppins||||||||” text_font_size=”16px” min_height=”44px”]<\/p>\n
As already reported, APP advised funds controlled by APAX an the acquisition of Inventfarma and Neuraxpharm – the 2 first companies forming Nupharm. Following the creation of Nupharm, Claudio Albrecht assumed the role of a non executive Director from which he stepped down assuming his role in Stada. To guarantee continuity, Peter Prock assumes this role starting September 2017. Nupharm, a pan-European leader in the treatment of diseases related to the central nervous system (\u201cCNS\u201d), is the strategic combination of five leading specialty pharmaceutical companies: Neuraxpharm (Germany and Poland), Qualigen (Spain), FB Health (Italy), as well as Laboratorios Lesvi and Inke (Spain). NuPharm develops and markets branded, generic and nutraceutical pharmaceutical products, offering a wide range of differentiated and affordable CNS treatment options to healthcare professionals and industry partners. With an international presence in more than 50 countries, the Group also manufactures finished dosage forms and active pharmaceutical ingredients dedicated to CNS and respiratory indications.<\/p>\n
[\/et_pb_text][et_pb_divider color=”#edbb5f” divider_weight=”2px” _builder_version=”3.2″ max_width=”60px” module_alignment=”left” height=”2px” global_module=”350″][\/et_pb_divider][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Contact” _builder_version=”3.27.4″ custom_padding=”2px|0px|18px|0px||” animation_style=”zoom” global_module=”339″ saved_tabs=”all”][et_pb_row column_structure=”1_4,1_2,1_4″ _builder_version=”3.27.4″ max_width=”1440px” animation_style=”slide” animation_duration=”1500ms”][et_pb_column type=”1_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text module_id=”contact” _builder_version=”3.27.4″ text_font=”Work Sans|600|||||||” text_line_height=”2em” header_font=”||||||||” header_2_font=”Suranna|||on|||||” header_2_font_size=”3vw” header_2_line_height=”1.2em” header_3_font=”Raleway|700||on|||||” header_3_font_size=”12px” header_3_letter_spacing=”1.5px” header_3_line_height=”2em” header_4_font=”||||||||” header_2_font_size_tablet=”5vw” header_2_font_size_phone=”24px” header_2_font_size_last_edited=”on|phone” border_color_all=”#f3f1f2″ locked=”off”]<\/p>\n
[\/et_pb_text][et_pb_text content_tablet=”” content_phone=”” content_last_edited=”on|desktop” module_id=”contact” _builder_version=”3.27.4″ text_font=”Poppins||||||||” text_font_size=”16px” text_line_height=”1em” header_font=”Poppins||||||||” header_2_font=”Suranna|||on|||||” header_2_font_size=”3vw” header_2_line_height=”1.2em” header_3_font=”Raleway|700||on|||||” header_3_font_size=”12px” header_3_letter_spacing=”1.5px” header_3_line_height=”2em” header_4_font=”||||||||” header_2_font_size_tablet=”5vw” header_2_font_size_phone=”24px” header_2_font_size_last_edited=”on|phone” border_color_all=”#f3f1f2″ locked=”off”]<\/p>\n
Albrecht, Prock & Partners AG<\/p>\n
B\u00f6dlistrasse 3c<\/p>\n
CH-6314 Unteraegeri – Zug, Switzerland<\/p>\n
office(at)ca-pp.net<\/p>\n
[\/et_pb_text][et_pb_contact_form email=”office@ca-pp.net” _builder_version=”3.27.2″ custom_button=”on” button_text_color=”#a0a0a0″ border_color_all=”#000000″][et_pb_contact_field field_id=”Name” field_title=”Name” _builder_version=”3.16″ button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_contact_field][et_pb_contact_field field_id=”Email” field_title=”Email Address” field_type=”email” _builder_version=”3.16″ button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_contact_field][et_pb_contact_field field_id=”Message” field_title=”Message” field_type=”text” fullwidth_field=”on” _builder_version=”3.16″ button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_contact_field][\/et_pb_contact_form][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"
As already reported, APP advised funds controlled by APAX an the acquisition of Inventfarma and Neuraxpharm – the 2 first companies forming Nupharm. Following the creation of Nupharm, Claudio Albrecht assumed the role of a non executive Director from which he stepped down assuming his role in Stada. To guarantee continuity, Peter Prock assumes […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":""},"categories":[2],"tags":[],"_links":{"self":[{"href":"https:\/\/app-pharma.care\/index.php?rest_route=\/wp\/v2\/posts\/498"}],"collection":[{"href":"https:\/\/app-pharma.care\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/app-pharma.care\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/app-pharma.care\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/app-pharma.care\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=498"}],"version-history":[{"count":6,"href":"https:\/\/app-pharma.care\/index.php?rest_route=\/wp\/v2\/posts\/498\/revisions"}],"predecessor-version":[{"id":911,"href":"https:\/\/app-pharma.care\/index.php?rest_route=\/wp\/v2\/posts\/498\/revisions\/911"}],"wp:attachment":[{"href":"https:\/\/app-pharma.care\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=498"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/app-pharma.care\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=498"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/app-pharma.care\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=498"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}